Magda Marquet's Trading History
| TRAXFirst Tracks Biotherapeutics Inc | Jun 17, 2026 | Director | Uninformative Buy | 107.82K | $719.48K | |
| IMMXImmix Biopharma | May 29, 2026 | Director | Uninformative Buy | ― | $555.59K | |
| ANABAnaptysBio | Jan 16, 2026 | Director | Uninformative Buy | 287.21K | $479.42K | |
| ARCTArcturus Therapeutics | Jun 18, 2024 | Director | Uninformative Buy | 97.06K | $309.65K | |
| RNAZTransCode Therapeutics | ― | Director | ― | ― | ||
| PFNXPfenex | ― | ― | ― | ― |
You May Also Like
Magda Marquet insider profile FAQ
What is the percentage of profitable transactions made by Magda Marquet?
The percentage of profitable transactions made by Magda Marquet is 33%.
What is the average return per transaction made by Magda Marquet?
The average return per transaction made by Magda Marquet is 48.50%.
What stocks does Magda Marquet hold?
Magda Marquet holds: TRAX, ARCT, PFNX, ANAB, RNAZ, IMMX stocks.
What was Magda Marquet’s latest transaction?
Magda Marquet’s latest transaction was an Uninformative Buy of $107.82K.
What was Magda Marquet's most profitable transaction?
Magda Marquet’s most profitable transaction was an Informative Buy of ARCT stock on September 17, 2019. The return on the trade was 316.90%.
What is Magda Marquet's role in First Tracks Biotherapeutics Inc?
Magda Marquet's role in First Tracks Biotherapeutics Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.